Total Payments
$32,977
2024 Payments
$7,778
Companies
66
Transactions
831
Medicare Patients
6,425
Medicare Billing
$727,025
Payment Breakdown by Category
Food & Beverage$24,943 (75.6%)
Travel$5,334 (16.2%)
Consulting$2,277 (6.9%)
Education$422.44 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,943 | 802 | 75.6% |
| Travel and Lodging | $5,334 | 19 | 16.2% |
| Consulting Fee | $2,277 | 4 | 6.9% |
| Education | $422.44 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,265 | 109 | $0 (2024) |
| Inari Medical, Inc. | $3,245 | 31 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,154 | 41 | $0 (2020) |
| Boston Scientific Corporation | $2,148 | 37 | $0 (2024) |
| CORDIS US CORP. | $2,125 | 3 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,347 | 16 | $0 (2023) |
| Medtronic, Inc. | $1,302 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,171 | 58 | $0 (2024) |
| Silk Road Medical, Inc. | $1,165 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,089 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,778 | 131 | CORDIS US CORP. ($2,125) |
| 2023 | $6,487 | 145 | Abbott Laboratories ($2,042) |
| 2022 | $4,447 | 101 | Silk Road Medical, Inc. ($1,165) |
| 2021 | $2,484 | 74 | Abbott Laboratories ($686.65) |
| 2020 | $1,439 | 57 | Medtronic Vascular, Inc. ($189.56) |
| 2019 | $4,951 | 110 | Medtronic Vascular, Inc. ($1,950) |
| 2018 | $2,308 | 110 | Abbott Laboratories ($576.47) |
| 2017 | $3,082 | 103 | BOSTON SCIENTIFIC CORPORATION ($1,093) |
All Payment Transactions
831 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Vascular | ||||||
| 12/20/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: Vascular | ||||||
| 12/19/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Vascular | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $123.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Cardiovascular | ||||||
| 12/06/2024 | CORDIS US CORP. | SELUTION SLRPTCA (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: DEVICES | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Vascular | ||||||
| 11/26/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Vascular | ||||||
| 11/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $139.99 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $96.25 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $179.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $41.76 | General |
| Category: VTE | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,707 | 2,548 | $599,204 | $202,783 |
| 2022 | 16 | 1,617 | 2,496 | $664,194 | $200,667 |
| 2021 | 20 | 1,555 | 2,251 | $529,594 | $168,043 |
| 2020 | 20 | 1,546 | 2,242 | $509,117 | $155,532 |
Total Patients
6,425
Total Services
9,537
Medicare Billing
$727,025
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 513 | $115,425 | $49,634 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 170 | 342 | $75,240 | $33,251 | 44.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 36 | 66 | $39,600 | $23,592 | 59.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 162 | $70,470 | $22,935 | 32.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 127 | 130 | $97,370 | $20,332 | 20.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 37 | 37 | $57,054 | $13,201 | 23.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 102 | $15,606 | $6,717 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $19,332 | $6,698 | 34.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 38 | 140 | $21,980 | $6,247 | 28.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 91 | 91 | $9,082 | $4,941 | 54.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 280 | 422 | $28,274 | $4,483 | 15.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 15 | $18,570 | $3,280 | 17.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 47 | 51 | $15,198 | $2,622 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 260 | 368 | $4,094 | $2,422 | 59.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $9,732 | $1,885 | 19.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 30 | 31 | $1,302 | $337.28 | 25.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 12 | 12 | $876.00 | $204.86 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 271 | 572 | $128,700 | $54,288 | 42.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 34 | 65 | $39,000 | $23,449 | 60.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 106 | 120 | $52,200 | $19,440 | 37.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 121 | 122 | $89,246 | $16,780 | 18.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 183 | $40,260 | $15,505 | 38.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 33 | 34 | $52,428 | $12,831 | 24.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 21 | 22 | $50,226 | $11,440 | 22.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 142 | $21,726 | $8,190 | 37.7% |
About Dr. Henry Cusnir, MD
Dr. Henry Cusnir, MD is a Interventional Cardiology healthcare provider based in Plantation, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215012844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Cusnir, MD has received a total of $32,977 in payments from pharmaceutical and medical device companies, with $7,778 received in 2024. These payments were reported across 831 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($24,943).
As a Medicare-enrolled provider, Cusnir has provided services to 6,425 Medicare beneficiaries, totaling 9,537 services with total Medicare billing of $727,025. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Plantation, FL
- Active Since 10/25/2006
- Last Updated 03/02/2018
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1215012844
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $2,641
- AMPLATZER AMULET (Device) $2,043
- Reveal LINQ (Device) $1,831
- XARELTO (Drug) $1,148
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,085
- GENERAL - VASCULAR ACCESS (Device) $1,033
- JARDIANCE (Drug) $976.92
- BRITE TIP (Device) $875.00
- Repatha (Biological) $792.06
- Impella (Device) $789.47
- SELUTION SLRPTCA (Device) $750.00
- ENROUTE Transcarotid Stent (Device) $632.59
- Confirm Rx (Device) $622.24
- ENTRESTO (Drug) $543.22
- ENROUTE Transcarotid Neuroprotection System (Device) $532.90
- Coronary Orbital Atherectomy System (Device) $521.52
- EMERALD (Device) $500.00
- CT THROMBECTOMY SYSTEM KIT (Device) $456.18
- ELIQUIS (Drug) $439.19
- BRILINTA (Drug) $434.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.